Clinical Trials
2 trialsNCT05941325 2026-05-14
A Single-arm, Open-label, Single-center Prospective Study of Fruquintinib Combined With Envafolimab in the Treatment of Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma
Shanghai 6th People's Hospital
Phase 2 Suspended
NCT05142631 2022-03-02
Fruquintinib in the Treatment of Soft Tissue Sarcoma
Fudan University
Phase 2 Unknown